Alkermes plc
ALKS
Xếp hạng trong cổ phiếu
#2596
Alkermes plc, a biopharmaceutical company, engages in the research,... Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
Giá cổ phiếu
$43.77
Vốn hóa thị trường
$7.34B
Thay đổi (1 ngày)
-0.77%
Thay đổi (1 năm)
39.17%
Quốc gia
IE
Giao dịch Alkermes plc (ALKS)
Danh mục
Healthcare
Lịch sử giá cổ phiếu của Alkermes plc (ALKS)
Giá đóng cửa cao nhất: $41.35 vào 2026-10-01
Giá đóng cửa thấp nhất: $5.16 vào 1991-07-01
Giá đóng cửa thấp nhất: $5.16 vào 1991-07-01
Lịch sử giá cổ phiếu của Alkermes plc từ 1991 đến 2026
Hiệu suất giá cổ phiếu hàng năm
| Năm | Hiệu suất |
|---|---|
| 2026 (TTM) | 31.77% |
| 2025 | -5.27% |
| 2024 | 11.89% |
| 2023 | 5.82% |
| 2022 | 11.46% |
| 2021 | 11.60% |
| 2020 | -1.81% |
| 2019 | -34.83% |
| 2018 | -39.69% |
| 2017 | -5.34% |
| 2016 | -25.70% |
| 2015 | 33.49% |
| 2014 | 40.87% |
| 2013 | 110.47% |
| 2012 | 17.80% |
| 2011 | 38.74% |
| 2010 | 27.92% |
| 2009 | -2.84% |
| 2008 | -37.96% |
| 2007 | 6.15% |
| 2006 | -21.96% |
| 2005 | 26.96% |
| 2004 | 12.48% |
| 2003 | 80.01% |
| 2002 | -71.44% |
| 2001 | -23.13% |
| 2000 | 39.57% |
| 1999 | 136.44% |
| 1998 | 5.32% |
| 1997 | 0.19% |
| 1996 | 173.62% |
| 1995 | 175.36% |
| 1994 | -68.53% |
| 1993 | -17.41% |
| 1992 | -38.13% |
| 1991 | 0.00% |
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
| Công ty | Giá cổ phiếu | Thay đổi 1năm% | Quốc gia |
|---|---|---|---|
| $520.06 | 22.00% |
US
|
|
| $249.65 | 808.13% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $887.09 | 6.27% |
NL
|
|
| $752.87 | 7.40% |
CH
|
